CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
Mucopolysaccharidosis (MPS) syndromes are a group of heterogeneous genetic disorders in terms of genetic basis and clinical manifestations, ranging from mild to fatal forms. There are a number of applied or prospective treatment modalities for MPS, including bone marrow transplantation, enzyme repla...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2024-09-01
|
| Edice: | Biochemistry and Biophysics Reports |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2405580824001353 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|